News

Exactech Schedules Second Quarter 2014 Earnings Release and Conference Call

GAINESVILLE, Fla. – July 10, 2014 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its second quarter 2014 financial results on Monday, July 28th, 2014. A copy of the earnings release will be available at http://www.hawkassociates.com.

Read More…

Exactech Launches New Porous Technology for Total Knee Arthroplasty

Gainesville, Fla. – July 3, 2014 – Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today the international launch of Optetrak Logic® Porous, a new porous technology for total knee arthroplasty.

Read More…

Twenty ExactechGPS® Guided Personalized Surgery Abstracts Accepted into Five Leading Orthopaedic Conferences

Gainesville, Fla. – June 11, 2014 – Twenty Exactech Knee abstracts, featuring the company’s breakthrough technology ExactechGPS® Guided Personalized Surgery, have been accepted into five leading orthopaedic conferences:

Read More…

Exactech Announces First International Introduction of ExactechGPS® Guided Personalized Surgery at 15th EFORT Congress

Gainesville, Fla. – June 4, 2014 – Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today its slate of products to be featured at the company’s technical exhibit, Capital Hall, Booth #16, at the 15th Annual Congress of the European Federation of National Associations of Orthopaedics and Traumatology (EFORT) June 4-6 in London.

Read More…

Exactech Q1 Revenue Up 7% to $63.3 Million. Net Income up 9% to $4.2 Million. Diluted EPS $0.30 vs. $0.29.

GAINESVILLE, Fla. – April 21, 2014 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today revenue of $63.3 million for the first quarter of 2014, a 7% increase over $59.3 million in the first quarter of 2013. Net income was $4.2 million, or $0.30 per diluted share, compared to $3.9 million, or $0.29 per diluted share, in the same quarter a year ago.

Read More…

Exactech Schedules First Quarter 2014 Earnings Release and Conference Call

Gainesville, Fla. – April 9, 2014 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its first quarter 2014 financial results on Monday, April 21st, 2014. A copy of the earnings release will be available at http://www.hawkassociates.com.

Read More…

Exactech To Conduct Intercontinental Masters Course in Shoulder Arthroplasty

Gainesville, Fla. – April 3, 2014 – Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that it will conduct an intercontinental medical education course in shoulder arthroplasty to be held simultaneously in Rio de Janeiro, Brazil and Venice, Italy, on April 3-4, 2014.

Read More…

Exactech Promotes President David Petty To Chief Executive Officer; Dr. Bill Petty Named Executive Chairman

Gainesville, Fla. – March 26, 2014 – Exactech, Inc. (Nasdaq: EXAC) is a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials. The company announced today that President David Petty has been promoted to Chief Executive Officer effective immediately. Dr. Bill Petty, co-founder and CEO of the company since 1985, was named Executive Chairman.

Read More…

Exactech Knee, Hip and Shoulder Innovations Presented at the 2014 Orthopaedic Research Society Annual Meeting

Gainesville, Fla. – March 24, 2014 – Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, presented scientific posters and presentations regarding its latest advancements for shoulder and knee replacement surgery during the 2014 Orthopaedic Research Society annual meeting in New Orleans.

Read More…

ExactechGPS®: Guided Personalized Surgery Takes Main Stage Among Exactech’s Orthopaedic Innovations at AAOS 2014 Annual Meeting in New Orleans.

Gainesville, Fla. – March 11, 2014 – Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today its line up of products to be unveiled at the company’s newly designed educational exhibit, booth #2261, at the American Academy of Orthopedic Surgeons (AAOS) 2014 Annual Meeting March 11 – 15 in New Orleans, LA.

Read More…

Exactech Broadens Equinoxe® Shoulder System With Introduction Of Resurfacing Humeral Head

GAINESVILLE, Fla. -- March 7, 2014 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today successful first surgeries using the company’s new Equinoxe® Resurfacing Humeral Head, which expands Exactech’s Equinoxe® Platform Shoulder System.

Read More…

Exactech Celebrates 20 Years of Exactech Knee with Launch of New Real-Time Patient-Specific Solution in TKA

GAINESVILLE, Fla. (March 5, 2014) – Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products, commemorates the twentieth anniversary of its knee system with the launch of ExactechGPS® Guided Personalized Surgery, the first advanced surgical technology to provide orthopaedic surgeons with a truly real-time patient-specific solution in total knee arthroplasty.

Read More…

Exactech 2013 Revenue Up 6% to $237.1M, Net Income Up 21% to $15.4M, EPS $1.12

GAINESVILLE, Fla. – February 19, 2014 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today that revenue for 2013 increased 6% to $237.1 million from $224.3 million in 2012. Diluted earnings per share for the year was $1.12 based on net income of $15.4 million, representing a 21% increase compared to net income of $12.7 million or $0.96 diluted earnings per share during 2012

Read More…

Exactech Schedules Fourth Quarter and Year End 2013 Earnings Release and Conference Call

GAINESVILLE, Fla. – February 4, 2014 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its fourth quarter and year end 2013 financial results on Wednesday, February 19th, 2014. A copy of the earnings release will be available at http://www.hawkassociates.com

Read More…

Exactech Expands Medical Education Initiatives Through Its Own Channel on VuMedi

GAINESVILLE, Fla. – Jan. 8, 2014 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today Exactech CEO Bill Petty, MD, is scheduled to moderate a live medical education webinar where nearly 1000 orthopaedic surgeons from around the world are registered to share best practices and explore new concepts in shoulder reconstruction. “New Concepts in Shoulder Arthroplasty” will air on the website VuMedi on Thursday, January 9, from 8:00 – 9:30 PM EST.

Read More…